What are the indications for margetuximab? How effective is it?

Margetuximab is a humanized monoclonal antibody mainly used to treat HER2-positive breast cancer and gastric cancer. Its mechanism of action is to inhibit the growth of cancer cells and activate the immune system by binding to the HER2 receptor. HER2 (human epidermal growth factor receptor 2) is a receptor that is abnormally highly expressed in many cancers, especially breast and gastric cancers. Margetuximab exerts its anti-tumor effect by targeting the HER2 receptor and is suitable for patients who are HER2-positive and have failed or relapsed after other treatments (such as trastuzumab). It not only directly inhibits the growth of tumor cells, but also further activates the immune system to eliminate tumor cells by enhancing antibody-dependent cell-mediated cytotoxicity (ADCC).

In clinical studies, margituximab has shown effectiveness in treating HER2positive breast cancer and gastric cancer. Especially in patients who are resistant to traditional treatments (such as trastuzumab), margetuximab has shown good efficacy. Take the MARGARET study as an example. This study evaluated the therapeutic effect of margetuximab combined with chemotherapy in patients with HER2 positive advanced breast cancer. The results of the study showed that the median overall survival of the margetuximab combined with chemotherapy group was significantly prolonged, and the patient's survival benefit was improved compared with the trastuzumab treatment group. In addition to extending survival, margetuximab also improved patients' progression-free survival (PFS), suggesting that it is also effective at inhibiting cancer progression.

In addition, margituximab has also shown therapeutic potential in patients with HER2 positive gastric cancer. In a IMpassion130 study, margetuximab was shown to be more effective than traditional chemotherapy when used alone or in combination with chemotherapy. Although the prognosis of patients with gastric cancer is generally poor, margituximab provides a new treatment option for these patients, especially when traditional therapies are ineffective.

Reference materials:https://www.margenza.com/